Ozempic 2025 Sales Representative. Despite ongoing economic uncertainty, 2025 should hold more promise for retailers and brands than this past year, offering early opportunities for brands that want to tap. When it comes to understanding the difference between a pharma product rep and an msl, 60 per cent of gps and 49 per cent of specialists cannot differentiate between the two roles,.
Diabetes medication to remain in short supply throughout 2025, manufacturer warns efforts to boost the production of ozempic (semaglutide) are not expected to alleviate. Consider the ongoing shortage when prescribing ozempic, inform patients that supply is expected to be limited in 2025, and discuss alternative treatments when patients are.
About the author